A tryptophan metabolite prevents depletion of circulating endothelial progenitor cells in systemic low-grade inflammation

BackgroundChronic systemic inflammation reduces the bioavailability of circulating endothelial progenitor cells (EPCs). Indoleamine 2,3-dioxygenase 1 (IDO1), a key enzyme of immune tolerance catalyzing the initial step of tryptophan degradation along the so-called l-kynurenine (l-kyn) pathway, that...

Full description

Bibliographic Details
Published in:	Frontiers in Immunology
Main Authors:	Massimo R. Mannarino, Vanessa Bianconi, Giulia Scalisi, Luca Franceschini, Giorgia Manni, Alessia Cucci, Francesco Bagaglia, Giulia Mencarelli, Francesco Giglioni, Doriana Ricciuti, Filippo Figorilli, Benedetta Pieroni, Elena Cosentini, Eleonora Padiglioni, Cecilia Colangelo, Dietmar Fuchs, Paolo Puccetti, Antonia Follenzi, Matteo Pirro, Marco Gargaro, Francesca Fallarino
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Subjects:	EPC — endothelial progenitor cells kynurenine (KYN) IDO1 enzyme low-grade inflammation IL-6 (interleukin 6) hs-CRP (high sensitivity C-reactive protein)
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.964660/full

Similar Items

Excessive progesterone impairs mouse decidualization via the Kyn-AhR pathway
by: Hui-Na Luo, et al.
Published: (2025-09-01)

Measuring the Systemic Inflammatory Response to On- and Off-Pump Coronary Artery Bypass Graft (CABG) Surgeries Using the Tryptophan/Kynurenine Pathway
by: Ahmed Farouk, et al.
Published: (2022-07-01)

A back-door insight into the modulation of Src kinase activity by the polyamine spermidine
by: Sofia Rossini, et al.
Published: (2023-06-01)

Exploring Early Detection of Frailty Syndrome in Older Adults: Evaluation of Oxi-Immune Markers, Clinical Parameters and Modifiable Risk Factors
by: Armanda Teixeira-Gomes, et al.
Published: (2021-12-01)

Modulation of immune cell function, IDO expression and kynurenine production by the quorum sensor 2-heptyl-3-hydroxy-4-quinolone (PQS)
by: Joy Ogbechi, et al.
Published: (2022-10-01)

The Effect of Body Mass Index on the KYN/TRP Pathway in the Pathogenesis of Periodontitis
by: Zeliha Güney, et al.
Published: (2023-12-01)

Tolerance to FVIII: Role of the Immune Metabolic Enzymes Indoleamine 2,3 Dyoxigenase-1 and Heme Oxygenase-1
by: Davide Matino, et al.
Published: (2020-04-01)

Cisplatin-Mediated IL-6 and IDO1 Suppression in Mesenchymal Stromal Cells: Implications for Tumor Microenvironment Modulation In Vitro
by: Armin von Fournier, et al.
Published: (2025-03-01)

Common mechanisms involved in lung cancer and depression: The dominant role of interleukin-6-IDO pathway in the lung-brain axis
by: Hai-Ting Tang, et al.
Published: (2023-04-01)

Molecular mechanisms involved in the IL-6-mediated upregulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression in the chorionic villi and decidua of women in early pregnancy
by: Rui Wang, et al.
Published: (2022-12-01)

Glia in the cytokine-mediated onset of depression:Fine tuning the immune response
by: Wendy Karen Jo, et al.
Published: (2015-07-01)

The interaction between dietary nitrates/nitrites intake and gut microbial metabolites on metabolic syndrome: a cross-sectional study
by: Atieh Mirzababaei, et al.
Published: (2024-09-01)

Discovery of a new highly pathogenic toxin involved in insect sepsis
by: Yuan Zhang, et al.
Published: (2023-12-01)

Dynamic Changes in Metabolites of the Kynurenine Pathway in Alzheimer’s Disease, and Huntington’s Disease: A Systematic Review of Pre-clinical Studies
by: Farzaneh Ahmadi, et al.
Published: (2024-01-01)

The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1
by: Eleonora Panfili, et al.
Published: (2023-04-01)

The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma
by: E Orecchini, et al.
Published: (2023-12-01)

The impact of Energy Performance Certificates on building deep energy renovation targets
by: Alexandros G. Charalambides, et al.
Published: (2019-01-01)

Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells
by: Sofia Rossini, et al.
Published: (2024-01-01)

Tumor Microenvironment‐Responsive Nanoparticles Enhance IDO1 Blockade Immunotherapy by Remodeling Metabolic Immunosuppression
by: Mengna Wang, et al.
Published: (2025-02-01)

The effect of prebiotic supplementation on serum levels of tryptophan and kynurenine in obese women with major depressive disorder: a double-blinded placebo-controlled randomized clinical trial
by: Fatemeh Khademi, et al.
Published: (2024-10-01)

Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification
by: Manxiu Huai, et al.
Published: (2024-05-01)

Natriuretic peptides as novel regulators of dendritic cells-mediated inflammation
by: Giorgia Manni, et al.
Published: (2025-07-01)

The Next Generation Wireless Network Deployment Using Machine Learning Based Multi-Objective Genetic Algorithm
by: Mahesh H. B, et al.
Published: (2025-06-01)

DEFINITION OF THE FIELDS OF THE BEST PRACTICES OF EPC (M)-PROJECT MANAGEMENT ON THE BASIS OF THE ANALYSIS OF THE WORLD MARKET
by: A. Laznik
Published: (2017-06-01)

DEFINITION OF THE FIELDS OF THE BEST PRACTICES OF EPC (M)-PROJECT MANAGEMENT ON THE BASIS OF THE ANALYSIS OF THE WORLD MARKET
by: A. Laznik
Published: (2019-02-01)

Regulation of IDO2 by the Aryl Hydrocarbon Receptor (AhR) in Breast Cancer
by: Sarah Y. Kado, et al.
Published: (2023-05-01)

Monitoring Approaches for New-Generation Energy Performance Certificates in Residential Buildings
by: Graziano Salvalai, et al.
Published: (2022-04-01)

Faecalibacterium prausnitzii Skews Human DC to Prime IL10-Producing T Cells Through TLR2/6/JNK Signaling and IL-10, IL-27, CD39, and IDO-1 Induction
by: Joudy Alameddine, et al.
Published: (2019-02-01)

Role of indoleamine 2, 3-dioxygenase 1 in immunosuppression of breast cancer
by: Pratyasha Sarangi
Published: (2024-10-01)

Immune Response and Serum Biomarker Screening in Pregnant Women with Influenza A Virus Infection: Insight into Susceptibility and Disease Severity
by: Suping Zhang, et al.
Published: (2025-06-01)

INVESTIGATION OF FORMS OF ENGINEERING CONTRACTS, CONCLUDED ON THE WORLD MARKET
by: A. Laznik
Published: (2017-06-01)

INVESTIGATION OF FORMS OF ENGINEERING CONTRACTS, CONCLUDED ON THE WORLD MARKET
by: A. Laznik
Published: (2019-02-01)

IDO1, FAT10, IFI6, and GILT Are Involved in the Antiretroviral Activity of γ-Interferon and IDO1 Restricts Retrovirus Infection by Autophagy Enhancement
by: Yoshinao Kubo, et al.
Published: (2022-07-01)

Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma
by: Xiaowei Liang, et al.
Published: (2023-05-01)

Pharmacologic Induction of Endotoxin Tolerance in Dendritic Cells by L-Kynurenine
by: Giorgia Manni, et al.
Published: (2020-03-01)

The Role of Nanopartikel Green Tea in Enhancing Endothelial Cell Migration in HUVEC Culture exposed to EPC-Conditioned Media in Hyperglycemic Conditions
by: Yuly Peristiowati, et al.
Published: (2024-10-01)

Activated Tryptophan-Kynurenine metabolic system in the human brain is associated with learned fear
by: Maria Rita Battaglia, et al.
Published: (2023-07-01)

Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC
by: Carminia Maria Della Corte, et al.
Published: (2022-11-01)

Inhibitory effects of flavonoids isolated from Sophora flavescens on indoleamine 2,3-dioxygenase 1 activity
by: Mincheol Kwon, et al.
Published: (2019-01-01)

Identifying and Evaluating the Risks of EPC Contract in Large Projects (Case Study of Mashhad Mall Project)
by: Amirreza Nazari, et al.
Published: (2018-11-01)